API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2023-82126.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215194
https://www.businesswire.com/news/home/20230613466829/en/Health-Sovereignty-EUROAPI-Supports-the-Supply-of-Essential-Medicines-to-France-and-Europe
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211452
https://www.newswise.com/articles/a-new-way-to-control-pain-after-knee-replacement-surgery
https://www.temad.com/en/morphine-sulfate-10-mg-tablets%d8%8c-api-and-finished-research-and-development-teamunveiling-of-three-new%d8%8c-and-innovative-products%d8%8c-of-temad-company%d8%8c-acetaminophen-325-oxycodone-5-mg/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-20-2022-1658293362.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bryant-ranch-prepack-inc-issues-voluntary-nationwide-recall-morphine-sulfate-30-mg-extended-release
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215584
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207270
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf
https://www.ethypharm.com/wp-content/uploads/2022/10/Morphine-ODT-EN.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-6-2021-1633509984.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203158
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207270
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-13-2021-1610520934.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212451
https://www.businesswire.com/news/home/20200623005067/en/Fresenius-Kabi-Expands-MicroVault%C2%AE-Packaging-include-Simplist%C2%AE
https://endpts.com/parkinsons-patients-experiencing-off-episodes-no-longer-need-to-rely-on-a-needle-for-an-antidote-with-new-fda-approval/
https://www.hhs.gov/about/news/2020/05/19/hhs-industry-partners-expand-us-based-pharmaceutical-manufacturing-covid-19-response.html
https://www.pharmacompass.com/pdf/news/pharmedium-services-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-sterile-products-1587014091.pdf
https://www.reuters.com/article/us-health-coronavirus-britain-medicines/uk-bans-parallel-exports-of-key-drugs-to-protect-supplies-idUSKBN2171Z8?feedType=RSS&feedName=healthNews
https://www.hikma.com/newsroom/article-i4595-civica-rx-and-hikma-announce-shipments-of-heparin-and-seven-other-essential-injectable-medicines/
https://www.federalregister.gov/documents/2019/12/02/2019-25946/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug
https://www.cnbc.com/2019/09/19/reuters-america-drugmaker-insys-wins-bankruptcy-court-approval-to-sell-off-opioid.html
https://www.reuters.com/article/us-usa-executions-exclusive/exclusive-while-battling-opioid-crisis-u-s-government-weighed-using-fentanyl-for-executions-idUSKCN1VY0YS?feedType=RSS&feedName=healthNews
https://www.prnewswire.com/news-releases/upsher-smith-launches-morphine-sulfate-tablets-300907859.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210610
https://www.reuters.com/article/us-usa-congress-fentanyl/top-lawmaker-signals-support-to-classify-all-illicit-fentanyl-copycats-like-heroin-idUSKCN1T5159
https://www.pharmacompass.com/pdf/news/Spectrum-Laboratory-Products-Receives-FDA-Warning-Letter-1560408618.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-10-2019-1554872020.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2019-1553661457.pdf
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-morphabond-er-206544-morphine-sulfate-15-mg-30-mg-60-mg-and-100-mg-tablets-1552998485.pdf
https://www.prnewswire.com/news-releases/piramal-critical-care-announces-the-us-launch-of-mitigo-300809900.html
https://www.ftc.gov/news-events/press-releases/2018/12/ftc-approves-teva-petition-reopen-modify-decision-order-case
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-November-7-2018-1541578996.pdf
https://endpts.com/trevena-crushed-as-analysts-count-red-flags-in-fdas-review-of-its-new-pain-med/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-embeda-22321-morphine-sulfate-and-naltrexone-hydrochloride-extended-release-capsules-1538195912.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-22-2018-1534903909.pdf
https://www.reuters.com/article/us-health-opioids-trend/use-of-prescription-opioids-in-u-s-remains-high-idUSKBN1KM6C7
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204393
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-2-2018-1525237297.pdf